HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The effects of recombinant desulphatohirudin on arterial thrombosis in rats.

Abstract
The role of thrombin in the formation of arterial thrombi is poorly understood. With the new availability of the specific thrombin inhibitor, recombinant desulphatohirudin, in large quantities this is now under investigation. A new model of arterial thrombosis in rats is described where a thrombus is formed on a mechanically injured vessel in vivo. Both platelet and fibrin deposition is inhibited by a recombinant hirudin (CGP 39393) at doses which prolong the activated partial thromboplastin time (APTT) to no more than 3-4 times the control level. In contrast, both unfractionated heparin and Fragmin only inhibit thrombosis when the APTT is excessively prolonged (i.e. to greater than 15 times the control value). It is concluded that CGP 39393 is an effective antithrombotic in arterial thrombosis at lower levels of anticoagulation than either heparin or Fragmin.
AuthorsM D Talbot, J Ambler, K D Butler, C M Lees, K A Mitchell, R F Peters, M F Tweed, R B Wallis
JournalHaemostasis (Haemostasis) Vol. 21 Suppl 1 Pg. 73-9 ( 1991) ISSN: 0301-0147 [Print] SWITZERLAND
PMID1654294 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Hirudins
  • Recombinant Proteins
  • desirudin
  • Fibrin
  • Heparin
Topics
  • Animals
  • Aorta, Abdominal (injuries)
  • Constriction
  • Fibrin (analysis)
  • Fibrinolytic Agents (therapeutic use)
  • Heparin (pharmacology)
  • Heparin, Low-Molecular-Weight (pharmacology)
  • Hirudin Therapy
  • Hirudins (analogs & derivatives)
  • Partial Thromboplastin Time
  • Platelet Aggregation (drug effects)
  • Rats
  • Recombinant Proteins (therapeutic use)
  • Thrombolytic Therapy
  • Thrombosis (drug therapy, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: